BACKGROUND: There is a controversy regarding the association between QRS width and ventricular arrhythmias (VAs). We hypothesized that predictive value of the QRS width could be improved if QRS width were considered in the context of the sum magnitude of the absolute QRST integral in 3 orthogonal leads sum absolute QRST integral (SAI QRST). We explored correlations between QRS width, SAI QRST, and VA in primary prevention implantable cardioverter-defibrillator (ICD) patients with structural heart disease. METHODS: Baseline orthogonal electrocardiograms were recorded at rest in 355 patients with implanted primary prevention ICDs (mean age, 59.5 ± 12.4 years; 279 male [79%]). Patients were observed prospectively at least 6 months; appropriate ICD therapies because of sustained VA served as end points. The sum magnitude of the absolute QRST integral in 3 orthogonal leads (SAI QRST) was calculated. RESULTS: During a mean follow-up of 18 months, 48 patients had sustained VA and received appropriate ICD therapies. There was no difference in baseline QRS width between patients with and those without arrhythmia (114.9 ± 32.8 vs 108.9 ± 24.7 milliseconds; P = .230). SAI QRST was significantly lower in patients with VA at follow-up than in patients without VA (102.6 ± 27.6 vs 112.0 ± 31.9 mV·ms; P = 0.034). Patients with SAI QRST (≤145 mV·ms) had a 3-fold higher risk of ventricular tachycardia (VT)/ventricular fibrillation (VF) (hazard ratio [HR], 3.25; 95% confidence interval [CI], 1.59-6.75; P = .001). In the univariate analysis, QRS width did not predict VT/VF. In the bivariate Cox regression model, every 1 millisecond of incremental QRS widening with a simultaneous 1 mV·ms SAI QRST decrease raised the risk of VT/VF by 2% (HR, 1.02; 95% CI, 1.01-1.03; P = .005). CONCLUSION: QRS widening is associated with ventricular tachyarrhythmia only if accompanied by low SAI QRST.
BACKGROUND: There is a controversy regarding the association between QRS width and ventricular arrhythmias (VAs). We hypothesized that predictive value of the QRS width could be improved if QRS width were considered in the context of the sum magnitude of the absolute QRST integral in 3 orthogonal leads sum absolute QRST integral (SAI QRST). We explored correlations between QRS width, SAI QRST, and VA in primary prevention implantable cardioverter-defibrillator (ICD) patients with structural heart disease. METHODS: Baseline orthogonal electrocardiograms were recorded at rest in 355 patients with implanted primary prevention ICDs (mean age, 59.5 ± 12.4 years; 279 male [79%]). Patients were observed prospectively at least 6 months; appropriate ICD therapies because of sustained VA served as end points. The sum magnitude of the absolute QRST integral in 3 orthogonal leads (SAI QRST) was calculated. RESULTS: During a mean follow-up of 18 months, 48 patients had sustained VA and received appropriate ICD therapies. There was no difference in baseline QRS width between patients with and those without arrhythmia (114.9 ± 32.8 vs 108.9 ± 24.7 milliseconds; P = .230). SAI QRST was significantly lower in patients with VA at follow-up than in patients without VA (102.6 ± 27.6 vs 112.0 ± 31.9 mV·ms; P = 0.034). Patients with SAI QRST (≤145 mV·ms) had a 3-fold higher risk of ventricular tachycardia (VT)/ventricular fibrillation (VF) (hazard ratio [HR], 3.25; 95% confidence interval [CI], 1.59-6.75; P = .001). In the univariate analysis, QRS width did not predict VT/VF. In the bivariate Cox regression model, every 1 millisecond of incremental QRS widening with a simultaneous 1 mV·ms SAI QRST decrease raised the risk of VT/VF by 2% (HR, 1.02; 95% CI, 1.01-1.03; P = .005). CONCLUSION: QRS widening is associated with ventricular tachyarrhythmia only if accompanied by low SAI QRST.
Authors: Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews Journal: N Engl J Med Date: 2002-03-19 Impact factor: 91.245
Authors: Mark T Kearney; Azfar Zaman; Dwain L Eckberg; Amanda J Lee; Keith A A Fox; Ajay M Shah; Robin J Prescott; William E Shell; Elizabeth Charuvastra; Timothy S Callahan; W Paul Brooksby; D Justin Wright; Nicholas P Gall; James Nolan Journal: J Card Fail Date: 2003-04 Impact factor: 5.712
Authors: Peter J Zimetbaum; Alfred E Buxton; William Batsford; John D Fisher; Gail E Hafley; Kerry L Lee; Michael F O'Toole; Richard L Page; Matthew Reynolds; Mark E Josephson Journal: Circulation Date: 2004-08-02 Impact factor: 29.690
Authors: Larisa G Tereshchenko; Alan Cheng; Jason Park; Nicholas Wold; Timothy E Meyer; Michael R Gold; Suneet Mittal; Jagmeet Singh; Kenneth M Stein; Kenneth A Ellenbogen Journal: Heart Rhythm Date: 2015-08-10 Impact factor: 6.343
Authors: Tor Biering-Sørensen; Muammar Kabir; Jonathan W Waks; Jason Thomas; Wendy S Post; Elsayed Z Soliman; Alfred E Buxton; Amil M Shah; Scott D Solomon; Larisa G Tereshchenko Journal: Circ Arrhythm Electrophysiol Date: 2018-03
Authors: Jonathan W Waks; Colleen M Sitlani; Elsayed Z Soliman; Muammar Kabir; Elyar Ghafoori; Mary L Biggs; Charles A Henrikson; Nona Sotoodehnia; Tor Biering-Sørensen; Sunil K Agarwal; David S Siscovick; Wendy S Post; Scott D Solomon; Alfred E Buxton; Mark E Josephson; Larisa G Tereshchenko Journal: Circulation Date: 2016-04-14 Impact factor: 29.690
Authors: Jonatan Jacobsson; Rasmus Borgquist; Christian Reitan; Elyar Ghafoori; Neal A Chatterjee; Muammar Kabir; Pyotr G Platonov; Jonas Carlson; Jagmeet P Singh; Larisa G Tereshchenko Journal: Am J Cardiol Date: 2016-05-14 Impact factor: 2.778
Authors: Larisa G Tereshchenko; Albert Feeny; Erica Shelton; Thomas Metkus; Andrew Stolbach; Ernest Mavunga; Shannon Putman; Frederick K Korley Journal: Ann Noninvasive Electrocardiol Date: 2016-06-06 Impact factor: 1.468